Motus Gi Holdings Inc Quick Ratio (MOTS) starting from the first quarter 2024 to first quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Motus Gi Holdings Inc   (MOTS)

Motus Gi Holdings Inc 's Quick Ratio

MOTS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2024, Quick Ratio fell to 1.55 below Motus Gi Holdings Inc average.

Within Medical Equipment & Supplies industry 104 other companies have achieved higher Quick Ratio than Motus Gi Holdings Inc in first quarter 2024. While Quick Ratio total ranking in the first quarter 2024 has deteriorated compared to the prior quarter from 901 to 1611.

Explain Quick Ratio?
How much Cash & cash equivalents MOTS´s has?
What are MOTS´s Current Liabilities?




MOTS Quick Ratio (Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
Y / Y Current Liabilities Change -27.07 % -35.38 % -18.62 % 11.64 % 42 %
Y / Y Cash & cash equivalent Change -42.83 % -64.69 % -56.94 % -45.92 % -57.48 %
Quick Ratio MRQ 1.55 1.6 1.35 1.91 1.98
MOTS's Total Ranking # 1611 # 901 # 1296 # 738 #
Seq. Current Liabilities Change 2.97 % -26.98 % -4.58 % 1.67 % -8.77 %
Seq. Cash & cash equivalent Change -0.28 % -13.38 % -32.82 % -1.47 % -38.41 %



Quick Ratio first quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 105
Healthcare Sector # 645
Overall Market # 1611


Quick Ratio Statistics
High Average Low
11.68 4.32 1.35
(Mar 31 2018)   (Sep 30 2023)




Financial Statements
Motus Gi Holdings Inc 's Current Liabilities $ 3 Millions Visit MOTS's Balance sheet
Motus Gi Holdings Inc 's Cash & cash equivalent $ 5 Millions Visit MOTS's Balance sheet
Source of MOTS's Sales Visit MOTS's Sales by Geography


Cumulative Motus Gi Holdings Inc 's Quick Ratio

MOTS's Quick Ratio for the trailling 12 Months

MOTS Quick Ratio

(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth -18.45 % -5.33 % 20.1 % 53.1 % -1.82 %
Y / Y Cash & cash equivalent TTM Growth -53.33 % -56.09 % -48.67 % -45.93 % -44.32 %
Quick Ratio TTM 1.61 1.72 2.07 2.36 2.81
Total Ranking TTM # 4287 # 3448 # 3517 # 2863 #
Seq. Current Liabilities TTM Growth -7.33 % -9.5 % -5.16 % 2.52 % 7.58 %
Seq. Cash & cash equivalent TTM Growth -13.3 % -24.59 % -17.01 % -13.99 % -18.43 %


On the trailing twelve months basis In spite of the year on year decrease in MOTS's Current Liabilities to $3.19 millions, cumulative Quick Ratio to 1.61 below the MOTS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 233 other companies have achieved higher Quick Ratio than Motus Gi Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2023 from 3448 to 4287.

Explain Quick Ratio?
How much Cash & cash equivalents MOTS´s has?
What are MOTS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 234
Healthcare Sector # 1089
Within the Market # 4287


trailing twelve months Quick Ratio Statistics
High Average Low
8.36 3.71 1.55
(Dec 31 2018)   (Mar 31 2024)




Companies with similar Quick Ratio in the quarter ending Mar 31 2024, within Medical Equipment & Supplies Industry Quick RatioMar 31 2024 MRQ Cash & cash equivalentMar 31 2024 MRQ Current Liabilities
Staar Surgical Co  4.26 $ 266.713  Millions$ 62.674  Millions
Agape Atp Corporation  4.24 $ 3.581  Millions$ 0.844  Millions
Nexalin Technology Inc   4.23 $ 2.144  Millions$ 0.507  Millions
Lemaitre Vascular Inc   4.04 $ 108.288  Millions$ 26.810  Millions
Tandem Diabetes Care Inc   4.03 $ 467.810  Millions$ 116.119  Millions
Glaukos Corp  3.78 $ 272.860  Millions$ 72.238  Millions
Cutera Inc   3.76 $ 105.444  Millions$ 28.057  Millions
Tactile Systems Technology Inc   3.72 $ 60.706  Millions$ 16.340  Millions
Lifeward ltd   3.62 $ 41.488  Millions$ 11.456  Millions
Anika Therapeutics Inc   3.54 $ 100.706  Millions$ 28.460  Millions
Apyx Medical Corp  3.53 $ 37.282  Millions$ 10.556  Millions
Strata Critical Medical Inc   3.52 $ 38.138  Millions$ 10.836  Millions
Neuronetics Inc   3.50 $ 47.730  Millions$ 13.647  Millions
Medinotec Inc   3.50 $ 2.809  Millions$ 0.803  Millions
Intuitive Surgical Inc   3.49 $ 4,800.100  Millions$ 1,375.100  Millions
Icad Inc  3.41 $ 20.284  Millions$ 5.944  Millions
Merit Medical Systems Inc  3.41 $ 581.921  Millions$ 170.872  Millions
Heartsciences Inc   3.32 $ 5.808  Millions$ 1.752  Millions
Pulmonx Corporation  3.29 $ 70.158  Millions$ 21.294  Millions
Pixie Dust Technologies Inc   3.22 $ 11.078  Millions$ 3.440  Millions
FAMILY OFFICE OF AMERICA, INC.  3.05 $ 0.091  Millions$ 0.030  Millions
Innovative Eyewear Inc   3.00 $ 2.649  Millions$ 0.884  Millions
Beyond Air Inc   2.98 $ 34.468  Millions$ 11.567  Millions
Aethlon Medical Inc   2.97 $ 5.442  Millions$ 1.830  Millions
Sensus Healthcare Inc   2.69 $ 14.728  Millions$ 5.473  Millions
Star Equity Holdings Inc   2.64 $ 20.237  Millions$ 7.661  Millions
Jin Medical International Ltd  2.47 $ 25.988  Millions$ 10.503  Millions
Tela Bio Inc   2.45 $ 37.143  Millions$ 15.179  Millions
Integra Lifesciences Holdings Corp  2.38 $ 663.100  Millions$ 278.250  Millions
Treace Medical Concepts Inc   2.34 $ 110.006  Millions$ 47.049  Millions

Date modified: 2026-09-12T06:23:09+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.